Market Research Future (MRFR) study on the world medical connector market 2020 reveals factors that can influence market rise. As per MRFR findings, the global medical connector market can rise at about 8% CAGR from 2017 to 2023. MRFR findings also states that the integrated systems market value can rise over USD 2 Bn by 2023. The high adoption of medical devices is observed as the critical factors that can increase the market size.
The rise in the utility of medical electronics, such as ultrasound, electrocardiography, defibrillators, Magnetic resonance imaging (MRI), surgical, diagnostic, heart-lung machines, and therapy systems can prompt the rise of the medical connector market growth. The growing applications of medical systems is attributed to the rise in the demand for medical connectors.
Read more@ https://www.marketresearchfuture.com/reports/medical-connector-market-4271
The segment study of the medical connector global market is based on offering, light source type, and applications. The material based segments of the medical connector market are plastic and metal among others. The connector size based segments of the medical connector market are 11mm -20 mm, <=10 mm, and >= 20 mm.
The regional study of medical connector market by MRFR across Asia pacific, North America, and Europe, followed by the Rest of the World reveals that the medical connector market in North America can lead through the years to come. The medical connector market share in North America can escalate due to the rise in investment made by giant companies in the production of innovations of medical applications, such as catheters, dental tools, sensors, electro surgery tools, defibrillators, ECG devices, respirators, and others.
Top Key Players
MRFR listed some well-known players of the medical connector global market. They are; Smiths Interconnect (U.K.), ITT Corporation (U.S.), Amphenol Corporation (U.S.), Delphi Automotive LLP. (U.K.), TE Connectivity Ltd. (Switzerland), Molex (U.S.), Fisher Connectors (Switzerland), Samtec (U.S.) Lemo S.A. (Switzerland), Esterline Corporation (U.S.), and among others.
